Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Novel patent CN115611860B details a safer high-yield nilaparib synthesis route eliminating sodium azide and chiral resolution for cost-effective manufacturing and supply chain stability.
Patent CN115403505B reveals a palladium-catalyzed route for indolone thioesters. This method offers significant cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN115872825A details a room-temperature gold carbene method for 1,3-disubstituted allenes, offering significant cost reduction in pharmaceutical intermediate manufacturing and enhanced supply chain reliability.
Patent CN116283527B reveals nickel-catalyzed tetralone synthesis offering high purity and cost efficiency for scalable pharmaceutical intermediates manufacturing supply chains.
Patent CN115286628B reveals efficient Pd-catalyzed carbonylation for indolo isoquinoline. Offers supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.
Novel palladium-catalyzed carbonylation route offers high-purity indolo[2,1a]isoquinoline intermediates with simplified processing and enhanced supply chain reliability for pharmaceutical manufacturing.
Patent CN113105402B reveals a metal-free iodine-promoted synthesis for trifluoromethyl-triazoles, offering significant cost reduction in API manufacturing and enhanced supply chain stability.
Novel metal-free route for trifluoromethyl pyrazole compounds ensures significant cost reduction and supply chain reliability for global pharmaceutical intermediate manufacturers seeking high purity.
Novel Pd-catalyzed multicomponent route avoids toxic CO gas, offering high efficiency and scalability for pharmaceutical intermediates.
Novel patent CN117263870B offers high-yield Resmetirom intermediate synthesis. Eliminates expensive reagents, ensures supply stability for pharmaceutical manufacturing.
Novel iridium-catalyzed methylation route for TNNI3K inhibitors offers green chemistry benefits and scalable API intermediate manufacturing solutions.
Patent CN113816955B reveals a high-purity route for RET kinase inhibitor intermediate. Discover cost-effective manufacturing and supply chain advantages.
Novel metal-free synthesis route for fluorinated heterocycles offers scalable production and cost efficiency for global pharmaceutical intermediate supply chains.
Discover a novel iodine-promoted synthesis for 5-trifluoromethyl-1,2,4-triazoles. A cost-effective, metal-free route for reliable pharmaceutical intermediate supply.
Novel palladium-catalyzed carbonylation route offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates manufacturing ensuring global compliance.
Patent CN115261896B reveals electrochemical synthesis for high-purity intermediates. Offers cost reduction and supply chain reliability for anticancer drug manufacturing.
Patent CN116640097B reveals metal-free triazole synthesis reducing costs and improving supply chain reliability for pharmaceutical intermediates globally through scalable sulfur-promoted cyclization methods.
Novel manganese-catalyzed C-H activation method for isoindolines. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel catalyst-free synthesis of 7-methylpyrazolopyrimidines via one-pot reaction. High regioselectivity and yield for pharmaceutical intermediates.
Patent CN111675662A reveals a novel iron-catalyzed route for high-purity quinazolinone intermediates. Discover cost-effective manufacturing and scalable supply solutions.